Dow Up1.32% Nasdaq Up1.60%

Acorda Therapeutics, Inc. (ACOR)

-NMS
35.03 2.76(8.55%) Oct 23, 4:00PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income 16,441   154,958   30,605  
Operating Activities, Cash Flows Provided By or Used In
Depreciation9,575  9,112  11,479  
Adjustments To Net Income34,386  (111,661)32,980  
Changes In Accounts Receivables(4,457)(3,499)(556)
Changes In Liabilities(11,930)1,939  (15,203)
Changes In Inventories(5,124)7,427  10,036  
Changes In Other Operating Activities394  (6,157)(3,005)
Total Cash Flow From Operating Activities 39,285   52,119   66,336  
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(4,043)(10,384)(2,192)
Investments(30,429)(57,705)(39,236)
Other Cash flows from Investing Activities(10,620)(3,194)(3,595)
Total Cash Flows From Investing Activities (45,092) (71,283) (45,023)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock12,786  4,339  3,962  
Net Borrowings(909)(1,253)(1,962)
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 11,968   3,086   2,000  
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents 6,161   (16,078) 23,313  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.